Loading market dashboard
111, Inc.
YIHealthcareNASDAQCN
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
111, Inc. Announces First Quarter 2026 Unaudited Financial Results PR Newswire SHANGHAI, June 4, 2026
Continuing Transition toward a More Asset-Light and Operationally Efficient Business Model Net Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-Year Total Marketplace (MP) Service Revenue Increased by 24.7% Year-over-Year Fulfillment Expenses as a Percentage of Revenue Improved by 10 Basis Points Year-over-Year SHANGHAI, June 4, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Net revenue amounted to RMB2.4 billion (US$342.4 million), representing a 33.1% decrease from RMB3.5 billion in the prior-year quarter.
Continuing Transition to an Asset-Light Business Model to Improve Overall Efficiency Delivered Non-GAAP Operating Profitability in Both Q4'25 and FY'25 Generated Positive Operating Cash Flow for Both Q4'25 and FY'25 Continued Gross Profit Margin Expansion for B2B Business in Both Q4'25 and FY'25 SHANGHAI, April 9, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. 2025 Executing Strategic Optimization: Embraces Asset-Light Partnership Network Growth In 2025, the Company proactively implemented strategic structural optimization by divesting its 100% equity interests in several subsidiaries.
